Cargando…

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia

AIMS: Barrett's oesophagus with indefinite for dysplasia (BE‐IND) is a subjective diagnosis with a low interobserver agreement (IOA) among pathologists and uncertain clinical implications. This study aimed to assess the utility of p53 immunohistochemistry (p53‐IHC) in assessing BE‐IND specimens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Januszewicz, Wladyslaw, Pilonis, Nastazja D, Sawas, Tarek, Phillips, Richard, O'Donovan, Maria, Miremadi, Ahmad, Malhotra, Shalini, Tripathi, Monika, Blasko, Adrienn, Katzka, David A, Fitzgerald, Rebecca C, di Pietro, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321087/ https://www.ncbi.nlm.nih.gov/pubmed/35274753 http://dx.doi.org/10.1111/his.14642

Ejemplares similares

The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study
por: Phillips, Richard, et al.
Publicado: (2021)

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot
por: Pilonis, Nastazja Dagny, et al.
Publicado: (2022)

Mutational load may predict risk of progression in patients with Barrett’s oesophagus and indefinite for dysplasia: a pilot study
por: Trindade, Arvind J, et al.
Publicado: (2019)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus
por: Januszewicz, Wladyslaw, et al.
Publicado: (2020)

The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus
por: di Pietro, Massimiliano, et al.
Publicado: (2015)

Optical Biopsy of Dysplasia in Barrett’s Oesophagus Assisted by Artificial Intelligence
por: van der Laan, Jouke J. H., et al.
Publicado: (2023)

Screening for Barrett’s Oesophagus: Are We Ready for it?
por: Yusuf, Aisha, et al.
Publicado: (2021)

Confocal endomicroscopy diagnostic criteria for early signet-ring cell carcinoma in hereditary diffuse gastric cancer
por: Pilonis, Nastazja D., et al.
Publicado: (2023)

Real-world implementation of non-endoscopic triage testing for Barrett’s oesophagus during COVID-19
por: Landy, R, et al.
Publicado: (2023)

Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia
por: di Pietro, Massimiliano, et al.
Publicado: (2018)

Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020)

The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett’s esophagus
por: Vithayathil, Mathew, et al.
Publicado: (2023)

Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning
por: Berman, Adam G., et al.
Publicado: (2022)

“Indefinite for Dysplasia” in Barrett's Esophagus: Inflammation and DNA Content Abnormality are Significant Predictors of Early Detection of Neoplasia
por: Choi, Won-Tak, et al.
Publicado: (2015)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

Diagnosis and management of Barrett’s oesophagus
por: Jankowski, Janusz, et al.
Publicado: (2010)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Barrett’s oesophagus: Current controversies
por: Amadi, Chidi, et al.
Publicado: (2017)

TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
por: di Pietro, Massimiliano, et al.
Publicado: (2020)

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus
por: Luebeck, Jens, et al.
Publicado: (2023)

Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study
por: Kadri, Sudarshan R, et al.
Publicado: (2010)

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

Screening for Barrett's oesophagus: is now the time?
por: Hanada, Yuri, et al.
Publicado: (2020)

Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus
por: Dunn, J M, et al.
Publicado: (2011)

Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus
por: Moyes, Lisa H, et al.
Publicado: (2016)

Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia
por: Horvath, Bela, et al.
Publicado: (2016)

What Is “Cold” and What Is “Hot” in Mucosal Ablation for Barrett’s Oesophagus-Related Dysplasia: A Practical Guide
por: Spadaccini, Marco, et al.
Publicado: (2023)

Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002)

Influence of Life Style Factors on Barrett's Oesophagus
por: Horna Strand, A., et al.
Publicado: (2014)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Application of a multi‐gene next‐generation sequencing panel to a non‐invasive oesophageal cell‐sampling device to diagnose dysplastic Barrett's oesophagus
por: Katz‐Summercorn, Annalise, et al.
Publicado: (2017)

Multi-omic cross-sectional cohort study of pre-malignant Barrett’s esophagus reveals early structural variation and retrotransposon activity
por: Katz-Summercorn, A. C., et al.
Publicado: (2022)

Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia
por: Nowicki-Osuch, Karol, et al.
Publicado: (2023)

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
por: Fitzgerald, Rebecca C, et al.
Publicado: (2020)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a21ok3i44a2ratp10bvh7qfabi